What is Tofacitinib?

Category: Prescription Drugs

Most popular types: Xeljanz Xeljanz XR

false

Tofacitinib is an oral medication that is known as a disease modifying antirheumatic drug. It is used in the treatment of adult patients with moderately- to severely-active rheumatoid arthritis who are unable to take or who have had an inadequate response to methotrexate.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 33 14
Alopecia areata 1 1
Arthritis pain 1 1
Headaches 1 2
Pain 1 1
Stiffness in morning 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
2
Moderate
0
Mild
5
None
10

Commonly reported side effects and conditions associated with Tofacitinib

Side effect Patients
Headaches 2
Dizziness 1
Fatigue 1
Hair loss 1
Heart palpitations 1
High cholesterol (hypercholesterolemia) 1

Show all 11 reported side effects

Dosages

Based on patients currently taking Tofacitinib

Dosage Patients
5 mg twice daily 8
11 mg daily 4
1 tablet(s) twice daily 2
5 mg daily 1
10 mg twice daily 1
20 mg daily 1
11 mg twice daily 1

Why patients stopped taking Tofacitinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 4
Doctor's advice 1
Other 1
Side effects too severe 1
See all 6 patients who've stopped taking Tofacitinib

Duration

Currently taking Tofacitinib

Duration Patients
Less than 1 month 1
1 - 6 months 2
6 months - 1 year 2
1 - 2 years 4
2 - 5 years 9
5 - 10 years 1

Stopped taking Tofacitinib

Duration Patients
Less than 1 month 3
1 - 6 months 2
1 - 2 years 1
Adherence
Adherence Evaluations
Always 13
Usually 3
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 16
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 1
$25-49 0
< $25 12
Not specified 2

What people switch to and from

Patients started taking Tofacitinib after stopping:

Treatment Patients
Adalimumab (Humira) 5
Methotrexate (Apo-Methotrexate) 5
Leflunomide (Arava) 3
Abatacept (Orencia) 2
Etanercept (Enbrel SureClick) 2

Show all 12 treatments patients report switching from

Patients stopped taking Tofacitinib and switched to:

Treatment Patients
Adalimumab (Humira) 2
Infliximab (Remicade) 1
Minocycline (Minocin) 1
Pregabalin (Lyrica) 1
Sulfasalazine (Salazopyrin) 1

Show all 6 treatments patients report switching to

Last updated:
There are no evaluations for Tofacitinib.